Abstract
Sinus bradycardia is a well-known consequence of stimulation of presynaptic α2 adrenergic receptors due the adminstration of dexmedetomidine. One of the most serious adverse effects of dexmedetomidine is cardiac arrest. Some cases demonstrating such an arrest due to the indiscriminate use of this drug were recently reported. We continuously administered dexmedetomidine to a 56-year-old male patient at a rate of 0.3 μg/kg/h (lower than the recommended dose) without initial dosing for sedation in an intensive care unit. The patient had undergone open cardiac surgery and atrial pacing was maintained at a fixed rate, 90/min. The PQ interval in electrocardiography gradually prolonged during the infusion; finally, complete atrioventricular block and subsequent cardiac arrest occurred. Immediate cardiopulmonary resuscitation was carried out, including re-intubation, and recovery of spontaneous circulation was attained 15 min after the event. The patient was discharged from hospital on the 25th postoperative day without any neurological complications.
Similar content being viewed by others
References
Shah AN, Koneru J, Nicoara A, Goldfeder LB, Thomas K, Ehlert FA. Dexmedetomidine related cardiac arrest in a patient with permanent pacemaker; a cautionary tale. Pacing Clin Electrophysiol. 2007;30:1158–60.
Nagasaka Y, Machino A, Fujikake K, Kwamoto E, Wakamatsu M. Cardiac arrest induced by dexmedetomidine. Masui. 2009;58:987–9 (Japanese with English abstract).
Bharati S, Pal A, Biswas C, Biswas R. Incidence of cardiac arrest increases with the indiscriminate use of dexmedetomidine: a case series and review of published case reports. Acta Anaesthesiol Taiwan. 2011;49:165–7.
Ingersoll-Weng E, Manecke Thistlethwaite GR Jr. Dexmedetomidine and cardiac arrest. Anesthesiology. 2004;100:738–9.
Muntazar M, Kumar FC. Cardiac arrest, a preventable yet a possible risk of dexmedetomidine: fact or fiction? Anesthesiology. 2004;101:1478–9.
Sichrovsky TC, Mittal S, Steinberg JS. Dexmedetomidine sedation leading to refractory cardiogenic shock. Anesth Analg. 2008;106:1784–6.
Ebert TJ, Hall JE, Bamey JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382–94.
Hendrickx JFA, Eger EI II, Sonner JM, Shafer SL. Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility. Anesth Analg. 2008;107:494–506.
Shepard SM, Tejman-Yarden S, Khanna S, Davis CK, Batra AS. Dexmedetomidine-related atrial standstill and loss of capture in a pediatric patient after congenital heart surgery. Crit Care Med. 2011;39:187–9.
Videira RLR, Ferreira RMV. Dexmedetomidine and asystole. Anesthesiology. 2004;101:1479.
Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother. 2007;41:245–52.
Shukry M, de Armendi AJ, Cure JA. Angiotensin-converting enzyme inhibitor and cardiac arrest following induction of anesthesia. Ann Card Anesth. 2010;13:72–3.
Zhang X, Schmidt U, Wain JC, Bigatello L. Bradycardia leading to asystole during dexmedetomidine infusion in an 18 year-old double-lung transplant recipient. J Clin Anesth. 2010;22:45–9.
Webb CA, Weyker PD, Flynn BC. Asystole after orthotopic lung transplantation: examining the interaction of cardiac denervation and dexmedetomidine. Case Rep Anesthesiol. 2012;2012:203240.
Conflict of interest
None of the authors of this report has any conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Takata, K., Adachi, Y.U., Suzuki, K. et al. Dexmedetomidine-induced atrioventricular block followed by cardiac arrest during atrial pacing: a case report and review of the literature. J Anesth 28, 116–120 (2014). https://doi.org/10.1007/s00540-013-1676-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-013-1676-7